---
title: "SLC9A6"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "### Gene Information"
tags: ['SLC9A6', 'GeneticInformation', 'GeneFunction', 'Mutation', 'RelatedDisease', 'Treatment', 'DrugResponse', 'MedicalResearch']
---

### Gene Information

Gene: SLC9A6

Function: This gene encodes a membrane protein that belongs to the sodium/hydrogen exchanger (NHE) family of proteins. The protein functions in intracellular pH regulation and cellular volume homeostasis and has been implicated in numerous human diseases.

External IDs: 

- Gene ID: 10479 
- Genomic location: Chromosome X: 115,181,245-115,384,268 
- Aliases: NHE6, KIAA0184

External Sites:

- HGNC: 10992 
- NCBI Entrez: 10479
- Ensembl: ENSG00000127540 
- OMIM: 300231 
- UniProtKB/Swiss-Prot: Q9Y6M3 

AA Mutation List and Mutation Type with dbSNP ID:  

- p.Lys263Glu, Missense Variant, rs104894761
- p.Asp365Gly, Missense Variant, rs368536039
- p.Leu479Pro, Missense Variant, rs374324728

Somatic SNVs/InDels with dbSNP ID:

- c.1285G>A, rs759350794
- c.1183A>G, rs875989079

Related Disease: Christianson Syndrome (CS) 

Treatment and Prognosis: There is currently no cure for Christianson Syndrome and treatment options aim to alleviate symptoms through medications and therapies. Prognosis varies depending on the severity of symptoms.

Drug Response: There is currently no FDA-approved treatment for Christianson Syndrome. Experimental treatments are under investigation.

Related Papers:

- Burrage, Lindsay C., et al. "Approaches to diagnose genetically unsolved rare neurological disorders." Neuropediatrics, vol. 51, no. 3, 2020, pp. 151-161., doi:10.1055/s-0040-1708501.
- Shashi, V., et al. "The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders." Genetics in Medicine, vol. 16, no. 2, 2014, pp. 176-182., doi:10.1038/gim.2013.109.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**